[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fYqipSRBaC0doqa3Rrt7B0lBtWhuhhH4i-kKktxxhg6U":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":83,"rows":90},"Loma Linda University",[4],304,false,57,15,245481,14,230,[14,17,20,23,26,28,31,33],{"name":15,"count":16},"Obesity",9,{"name":18,"count":19},"Inflammation",8,{"name":21,"count":22},"Autism Spectrum Disorder",6,{"name":24,"count":25},"Pain",5,{"name":27,"count":25},"Immune Response",{"name":29,"count":30},"Type 2 Diabetes",4,{"name":32,"count":30},"Postoperative Pain",{"name":34,"count":30},"Healthy",[36,41,46,51,55,59,63,68,73,78],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT03492671","Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer","2026-09","Gemcitabine 1000 mg",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT06363877","Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections","2026-10","Povidone-Iodine",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT05868525","Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).","2026-12","Aspirin 325Mg Tab, Aspirin 81Mg Tab",{"nctId":52,"briefTitle":53,"date":49,"intervention":54},"NCT06339203","Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)","Normal Saline",{"nctId":56,"briefTitle":57,"date":49,"intervention":58},"NCT04860141","Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.","Gabapentin 600mg",{"nctId":60,"briefTitle":61,"date":49,"intervention":62},"NCT07124533","Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences","Toothpaste",{"nctId":64,"briefTitle":65,"date":66,"intervention":67},"NCT04938765","Effect of Magnesium Sulfate Bolus on Intraoperative Neuromonitoring","2027-03","Magnesium sulfate",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT06550362","Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA","2027-05","iron sulfate",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT07536594","Relief Efficacy of Lidocaine Versus Morphine for Acute Renal Colic in the Emergency Department","2027-06","Lidocaine",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT05551104","Safest Choice of Antihypertensive Regimen for Postpartum Hypertension","2027-12","Oral Nifedipine",[84,85,86,87,88,89],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[91,146,167,188,206,228,260,282,306,324,342,365,383,428,446,484,510,528,555,581,599,617,643,661,688,706,732,750,776,805,823,841,867,885,912,930,954,981,1004,1032,1058,1093,1118,1143,1167,1192,1218,1242,1266,1290,1314,1332,1357,1380,1405,1431,1449,1473,1516,1556,1584,1612,1634,1661,1679,1697,1722,1740,1765,1783,1809,1834,1852,1878,1896,1914,1932,1950,1968,1994,2012,2037,2062,2088,2106,2131,2155,2181,2207,2225,2250,2277,2295,2313,2337,2364,2382,2400,2425],{"intervention":54,"totalTrials":30,"cells":92},{"EARLY_PHASE1":93,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":112,"NA":122},{"trials":94,"activeCount":95},[],0,{"trials":97,"activeCount":95},[],{"trials":99,"activeCount":95},[],{"trials":101,"activeCount":111,"soonestReadout":44},[102],{"nctId":42,"briefTitle":43,"status":103,"phases":104,"primaryCompletion":44,"completion":105,"start":106,"enrollment":107,"conditions":108,"interventions":110},"RECRUITING",[87],"2026-11","2024-06-03",1100,[109],"Surgical Site Infection",[45,54],1,{"trials":113,"activeCount":111,"soonestReadout":66},[114],{"nctId":64,"briefTitle":65,"status":103,"phases":115,"primaryCompletion":66,"completion":66,"start":116,"enrollment":117,"conditions":118,"interventions":121},[88],"2022-03-18",50,[119,120],"Intraoperative Neurophysiological Monitoring","Magnesium Sulfate",[67,54],{"trials":123,"activeCount":111,"soonestReadout":49},[124,132],{"nctId":52,"briefTitle":53,"status":103,"phases":125,"primaryCompletion":49,"completion":49,"start":126,"enrollment":127,"conditions":128,"interventions":131},[89],"2024-06-05",400,[129,130],"Cesarean Section Complications","Cesarean Section; Infection",[54],{"nctId":133,"briefTitle":134,"status":135,"phases":136,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":143},"NCT00616603","The Effects of Dexamethasone on the Duration of Sciatic Nerve Blocks","TERMINATED",[89],"2011-01","2011-05","2007-08",43,[142],"Total Knee Arthroplasty",[144,145,145,54],"Ropivacaine","Dexamethasone",{"intervention":50,"totalTrials":111,"cells":147},{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":165},{"trials":149,"activeCount":95},[],{"trials":151,"activeCount":95},[],{"trials":153,"activeCount":95},[],{"trials":155,"activeCount":95},[],{"trials":157,"activeCount":111,"soonestReadout":49},[158],{"nctId":47,"briefTitle":48,"status":103,"phases":159,"primaryCompletion":49,"completion":49,"start":160,"enrollment":161,"conditions":162,"interventions":164},[88],"2023-08-23",98,[163],"Blunt Cerebrovascular Injury",[50],{"trials":166,"activeCount":95},[],{"intervention":58,"totalTrials":111,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":175,"PHASE4":177,"NA":186},{"trials":170,"activeCount":95},[],{"trials":172,"activeCount":95},[],{"trials":174,"activeCount":95},[],{"trials":176,"activeCount":95},[],{"trials":178,"activeCount":111,"soonestReadout":49},[179],{"nctId":56,"briefTitle":57,"status":103,"phases":180,"primaryCompletion":49,"completion":49,"start":181,"enrollment":161,"conditions":182,"interventions":185},[88],"2021-06-16",[183,184],"Dental Pain and Sensation Disorder","Pain, Postoperative",[58],{"trials":187,"activeCount":95},[],{"intervention":67,"totalTrials":111,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":204},{"trials":191,"activeCount":95},[],{"trials":193,"activeCount":95},[],{"trials":195,"activeCount":95},[],{"trials":197,"activeCount":95},[],{"trials":199,"activeCount":111,"soonestReadout":66},[200],{"nctId":64,"briefTitle":65,"status":103,"phases":201,"primaryCompletion":66,"completion":66,"start":116,"enrollment":117,"conditions":202,"interventions":203},[88],[119,120],[67,54],{"trials":205,"activeCount":95},[],{"intervention":72,"totalTrials":111,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":226},{"trials":209,"activeCount":95},[],{"trials":211,"activeCount":95},[],{"trials":213,"activeCount":95},[],{"trials":215,"activeCount":95},[],{"trials":217,"activeCount":111,"soonestReadout":71},[218],{"nctId":69,"briefTitle":70,"status":219,"phases":220,"primaryCompletion":71,"completion":71,"start":221,"enrollment":222,"conditions":223,"interventions":225},"NOT_YET_RECRUITING",[88],"2026-05",100,[224],"Iron Deficiency Anemia",[72],{"trials":227,"activeCount":95},[],{"intervention":62,"totalTrials":229,"cells":230},2,{"EARLY_PHASE1":231,"PHASE1":233,"PHASE2":235,"PHASE3":237,"PHASE4":256,"NA":258},{"trials":232,"activeCount":95},[],{"trials":234,"activeCount":95},[],{"trials":236,"activeCount":95},[],{"trials":238,"activeCount":111,"soonestReadout":49},[239,251],{"nctId":240,"briefTitle":241,"status":242,"phases":243,"primaryCompletion":244,"completion":244,"start":245,"enrollment":246,"conditions":247,"interventions":249},"NCT05805865","Efficacy of Eco-Friendly Toothpaste Tablets Versus Conventional Toothpaste Using PI and GI Index","COMPLETED",[87],"2023-01-23","2023-01-03",40,[248],"Gingival Inflammation",[62,250],"Conventional Toothpaste",{"nctId":60,"briefTitle":61,"status":219,"phases":252,"primaryCompletion":49,"completion":49,"start":221,"enrollment":117,"conditions":253,"interventions":255},[87],[248,254],"Dental Caries",[62,250],{"trials":257,"activeCount":95},[],{"trials":259,"activeCount":95},[],{"intervention":250,"totalTrials":229,"cells":261},{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":278,"NA":280},{"trials":263,"activeCount":95},[],{"trials":265,"activeCount":95},[],{"trials":267,"activeCount":95},[],{"trials":269,"activeCount":111,"soonestReadout":49},[270,274],{"nctId":240,"briefTitle":241,"status":242,"phases":271,"primaryCompletion":244,"completion":244,"start":245,"enrollment":246,"conditions":272,"interventions":273},[87],[248],[62,250],{"nctId":60,"briefTitle":61,"status":219,"phases":275,"primaryCompletion":49,"completion":49,"start":221,"enrollment":117,"conditions":276,"interventions":277},[87],[248,254],[62,250],{"trials":279,"activeCount":95},[],{"trials":281,"activeCount":95},[],{"intervention":82,"totalTrials":111,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":302,"NA":304},{"trials":285,"activeCount":95},[],{"trials":287,"activeCount":95},[],{"trials":289,"activeCount":95},[],{"trials":291,"activeCount":111,"soonestReadout":81},[292],{"nctId":79,"briefTitle":80,"status":103,"phases":293,"primaryCompletion":81,"completion":81,"start":294,"enrollment":295,"conditions":296,"interventions":300},[87],"2023-05-08",500,[297,298,299],"Postpartum Complication","Maternal Hypertension","High Blood Pressure",[82,301],"Oral Labetalol",{"trials":303,"activeCount":95},[],{"trials":305,"activeCount":95},[],{"intervention":301,"totalTrials":111,"cells":307},{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":320,"NA":322},{"trials":309,"activeCount":95},[],{"trials":311,"activeCount":95},[],{"trials":313,"activeCount":95},[],{"trials":315,"activeCount":111,"soonestReadout":81},[316],{"nctId":79,"briefTitle":80,"status":103,"phases":317,"primaryCompletion":81,"completion":81,"start":294,"enrollment":295,"conditions":318,"interventions":319},[87],[297,298,299],[82,301],{"trials":321,"activeCount":95},[],{"trials":323,"activeCount":95},[],{"intervention":45,"totalTrials":111,"cells":325},{"EARLY_PHASE1":326,"PHASE1":328,"PHASE2":330,"PHASE3":332,"PHASE4":338,"NA":340},{"trials":327,"activeCount":95},[],{"trials":329,"activeCount":95},[],{"trials":331,"activeCount":95},[],{"trials":333,"activeCount":111,"soonestReadout":44},[334],{"nctId":42,"briefTitle":43,"status":103,"phases":335,"primaryCompletion":44,"completion":105,"start":106,"enrollment":107,"conditions":336,"interventions":337},[87],[109],[45,54],{"trials":339,"activeCount":95},[],{"trials":341,"activeCount":95},[],{"intervention":40,"totalTrials":111,"cells":343},{"EARLY_PHASE1":344,"PHASE1":346,"PHASE2":348,"PHASE3":359,"PHASE4":361,"NA":363},{"trials":345,"activeCount":95},[],{"trials":347,"activeCount":95},[],{"trials":349,"activeCount":111,"soonestReadout":39},[350],{"nctId":37,"briefTitle":38,"status":103,"phases":351,"primaryCompletion":39,"completion":39,"start":352,"enrollment":353,"conditions":354,"interventions":357},[86],"2019-07-17",30,[355,356],"Pancreas Adenocarcinoma","Resectable Pancreatic Cancer",[40,358],"nab-paclitaxel",{"trials":360,"activeCount":95},[],{"trials":362,"activeCount":95},[],{"trials":364,"activeCount":95},[],{"intervention":358,"totalTrials":111,"cells":366},{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":377,"PHASE4":379,"NA":381},{"trials":368,"activeCount":95},[],{"trials":370,"activeCount":95},[],{"trials":372,"activeCount":111,"soonestReadout":39},[373],{"nctId":37,"briefTitle":38,"status":103,"phases":374,"primaryCompletion":39,"completion":39,"start":352,"enrollment":353,"conditions":375,"interventions":376},[86],[355,356],[40,358],{"trials":378,"activeCount":95},[],{"trials":380,"activeCount":95},[],{"trials":382,"activeCount":95},[],{"intervention":77,"totalTrials":384,"cells":385},3,{"EARLY_PHASE1":386,"PHASE1":388,"PHASE2":390,"PHASE3":402,"PHASE4":404,"NA":406},{"trials":387,"activeCount":95},[],{"trials":389,"activeCount":95},[],{"trials":391,"activeCount":95},[392],{"nctId":393,"briefTitle":394,"status":395,"phases":396,"primaryCompletion":397,"start":398,"enrollment":95,"conditions":399,"interventions":401},"NCT01108562","Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion","WITHDRAWN",[85,86],"2008-08","2008-02",[400],"Postoperative Pain Management After Total Hip Arthroplasty",[77],{"trials":403,"activeCount":95},[],{"trials":405,"activeCount":95},[],{"trials":407,"activeCount":111,"soonestReadout":76},[408,417],{"nctId":409,"briefTitle":410,"status":395,"phases":411,"primaryCompletion":412,"completion":413,"start":414,"enrollment":95,"conditions":415,"interventions":416},"NCT00616850","Treatment of Postoperative Pain After Total Knee Arthroplasy Using Intravenous Lidocaine Infusion",[89],"2008-07","2009-07","2007-10",[142],[77],{"nctId":74,"briefTitle":75,"status":219,"phases":418,"primaryCompletion":76,"completion":419,"start":420,"enrollment":421,"conditions":422,"interventions":426},[89],"2028-06","2026-06",250,[423,424,425],"Renal Colic","Kidney Stones, Urolithiasis, Hypocitraturia","Opioid Use During Medical Care",[77,427],"Morphine 0,1 mg\u002Fkg",{"intervention":427,"totalTrials":111,"cells":429},{"EARLY_PHASE1":430,"PHASE1":432,"PHASE2":434,"PHASE3":436,"PHASE4":438,"NA":440},{"trials":431,"activeCount":95},[],{"trials":433,"activeCount":95},[],{"trials":435,"activeCount":95},[],{"trials":437,"activeCount":95},[],{"trials":439,"activeCount":95},[],{"trials":441,"activeCount":111,"soonestReadout":76},[442],{"nctId":74,"briefTitle":75,"status":219,"phases":443,"primaryCompletion":76,"completion":419,"start":420,"enrollment":421,"conditions":444,"interventions":445},[89],[423,424,425],[77,427],{"intervention":447,"totalTrials":229,"cells":448},"Prednisone",{"EARLY_PHASE1":449,"PHASE1":451,"PHASE2":453,"PHASE3":455,"PHASE4":471,"NA":482},{"trials":450,"activeCount":95},[],{"trials":452,"activeCount":95},[],{"trials":454,"activeCount":95},[],{"trials":456,"activeCount":95},[457],{"nctId":458,"briefTitle":459,"status":395,"phases":460,"primaryCompletion":461,"completion":462,"start":463,"enrollment":95,"conditions":464,"interventions":470},"NCT05095961","Pre-operative Steroids in CRSsP",[86,87],"2024-03","2024-08","2023-03",[465,466,467,468,469],"Chronic Sinus Disease","Chronic Sinusitis, Ethmoidal","Chronic Sinusitis, Sphenoidal","Chronic Sinusitis - Maxillary Bilateral","Chronic Sinusitis - Frontoethmoidal",[447],{"trials":472,"activeCount":95},[473],{"nctId":474,"briefTitle":475,"status":395,"phases":476,"primaryCompletion":477,"completion":477,"start":478,"enrollment":95,"conditions":479,"interventions":481},"NCT02119273","Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)",[88],"2018-04","2014-09",[480],"Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)",[447],{"trials":483,"activeCount":95},[],{"intervention":485,"totalTrials":111,"cells":486},"Exparel",{"EARLY_PHASE1":487,"PHASE1":489,"PHASE2":491,"PHASE3":493,"PHASE4":495,"NA":508},{"trials":488,"activeCount":95},[],{"trials":490,"activeCount":95},[],{"trials":492,"activeCount":95},[],{"trials":494,"activeCount":95},[],{"trials":496,"activeCount":95},[497],{"nctId":498,"briefTitle":499,"status":242,"phases":500,"primaryCompletion":501,"completion":501,"start":502,"enrollment":503,"conditions":504,"interventions":506},"NCT02805504","Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures",[88],"2022-05-09","2016-07-11",136,[505],"Urinary Tract Diseases",[485,507],"Marcaine",{"trials":509,"activeCount":95},[],{"intervention":507,"totalTrials":111,"cells":511},{"EARLY_PHASE1":512,"PHASE1":514,"PHASE2":516,"PHASE3":518,"PHASE4":520,"NA":526},{"trials":513,"activeCount":95},[],{"trials":515,"activeCount":95},[],{"trials":517,"activeCount":95},[],{"trials":519,"activeCount":95},[],{"trials":521,"activeCount":95},[522],{"nctId":498,"briefTitle":499,"status":242,"phases":523,"primaryCompletion":501,"completion":501,"start":502,"enrollment":503,"conditions":524,"interventions":525},[88],[505],[485,507],{"trials":527,"activeCount":95},[],{"intervention":529,"totalTrials":111,"cells":530},"Milnacipran",{"EARLY_PHASE1":531,"PHASE1":533,"PHASE2":535,"PHASE3":537,"PHASE4":539,"NA":553},{"trials":532,"activeCount":95},[],{"trials":534,"activeCount":95},[],{"trials":536,"activeCount":95},[],{"trials":538,"activeCount":95},[],{"trials":540,"activeCount":95},[541],{"nctId":542,"briefTitle":543,"status":395,"phases":544,"primaryCompletion":545,"completion":546,"start":547,"enrollment":95,"conditions":548,"interventions":552},"NCT01359826","The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients",[88],"2013-06","2013-11","2011-10",[549,550,551],"Systemic Lupus Erythematosus","Widespread Pain","Fibromyalgia",[529],{"trials":554,"activeCount":95},[],{"intervention":556,"totalTrials":111,"cells":557},"Omeprazole",{"EARLY_PHASE1":558,"PHASE1":560,"PHASE2":562,"PHASE3":564,"PHASE4":566,"NA":579},{"trials":559,"activeCount":95},[],{"trials":561,"activeCount":95},[],{"trials":563,"activeCount":95},[],{"trials":565,"activeCount":95},[],{"trials":567,"activeCount":95},[568],{"nctId":569,"briefTitle":570,"status":395,"phases":571,"primaryCompletion":572,"enrollment":95,"conditions":573,"interventions":576},"NCT02123498","The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux",[88],"2015-05",[574,575],"Eustachian Tube Dysfunction","Laryngopharyngeal Reflux",[556,577,578],"Ranitidine","Pantoprazole",{"trials":580,"activeCount":95},[],{"intervention":577,"totalTrials":111,"cells":582},{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":591,"NA":597},{"trials":584,"activeCount":95},[],{"trials":586,"activeCount":95},[],{"trials":588,"activeCount":95},[],{"trials":590,"activeCount":95},[],{"trials":592,"activeCount":95},[593],{"nctId":569,"briefTitle":570,"status":395,"phases":594,"primaryCompletion":572,"enrollment":95,"conditions":595,"interventions":596},[88],[574,575],[556,577,578],{"trials":598,"activeCount":95},[],{"intervention":578,"totalTrials":111,"cells":600},{"EARLY_PHASE1":601,"PHASE1":603,"PHASE2":605,"PHASE3":607,"PHASE4":609,"NA":615},{"trials":602,"activeCount":95},[],{"trials":604,"activeCount":95},[],{"trials":606,"activeCount":95},[],{"trials":608,"activeCount":95},[],{"trials":610,"activeCount":95},[611],{"nctId":569,"briefTitle":570,"status":395,"phases":612,"primaryCompletion":572,"enrollment":95,"conditions":613,"interventions":614},[88],[574,575],[556,577,578],{"trials":616,"activeCount":95},[],{"intervention":618,"totalTrials":111,"cells":619},"Prograf",{"EARLY_PHASE1":620,"PHASE1":622,"PHASE2":624,"PHASE3":626,"PHASE4":628,"NA":641},{"trials":621,"activeCount":95},[],{"trials":623,"activeCount":95},[],{"trials":625,"activeCount":95},[],{"trials":627,"activeCount":95},[],{"trials":629,"activeCount":95},[630],{"nctId":631,"briefTitle":632,"status":135,"phases":633,"primaryCompletion":634,"completion":635,"start":636,"enrollment":9,"conditions":637,"interventions":639},"NCT00983645","A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity",[88],"2012-10","2013-03","2004-10",[638],"Renal Transplant Rejection",[618,640],"Neoral",{"trials":642,"activeCount":95},[],{"intervention":640,"totalTrials":111,"cells":644},{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":651,"PHASE4":653,"NA":659},{"trials":646,"activeCount":95},[],{"trials":648,"activeCount":95},[],{"trials":650,"activeCount":95},[],{"trials":652,"activeCount":95},[],{"trials":654,"activeCount":95},[655],{"nctId":631,"briefTitle":632,"status":135,"phases":656,"primaryCompletion":634,"completion":635,"start":636,"enrollment":9,"conditions":657,"interventions":658},[88],[638],[618,640],{"trials":660,"activeCount":95},[],{"intervention":662,"totalTrials":111,"cells":663},"Cytisine",{"EARLY_PHASE1":664,"PHASE1":666,"PHASE2":668,"PHASE3":670,"PHASE4":672,"NA":686},{"trials":665,"activeCount":95},[],{"trials":667,"activeCount":95},[],{"trials":669,"activeCount":95},[],{"trials":671,"activeCount":95},[],{"trials":673,"activeCount":95},[674],{"nctId":675,"briefTitle":676,"status":242,"phases":677,"primaryCompletion":678,"completion":679,"start":680,"enrollment":681,"conditions":682,"interventions":684},"NCT04126135","Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy",[88],"2024-03-04","2024-04-20","2022-01-27",1307,[683],"Nicotine Addiction",[662,685],"Nicotine Replacement Therapy",{"trials":687,"activeCount":95},[],{"intervention":685,"totalTrials":111,"cells":689},{"EARLY_PHASE1":690,"PHASE1":692,"PHASE2":694,"PHASE3":696,"PHASE4":698,"NA":704},{"trials":691,"activeCount":95},[],{"trials":693,"activeCount":95},[],{"trials":695,"activeCount":95},[],{"trials":697,"activeCount":95},[],{"trials":699,"activeCount":95},[700],{"nctId":675,"briefTitle":676,"status":242,"phases":701,"primaryCompletion":678,"completion":679,"start":680,"enrollment":681,"conditions":702,"interventions":703},[88],[683],[662,685],{"trials":705,"activeCount":95},[],{"intervention":707,"totalTrials":111,"cells":708},"Hydrogen Peroxide Gel, 13 weeks",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":730},{"trials":710,"activeCount":95},[],{"trials":712,"activeCount":95},[],{"trials":714,"activeCount":95},[],{"trials":716,"activeCount":95},[],{"trials":718,"activeCount":95},[719],{"nctId":720,"briefTitle":721,"status":135,"phases":722,"primaryCompletion":723,"completion":723,"start":724,"enrollment":725,"conditions":726,"interventions":728},"NCT03262701","Adjunctive Hydrogen Peroxide for Periodontal Therapy",[88],"2021-02-08","2018-04-02",42,[727],"Periodontitis, Chronic",[707,729],"Hydrogen Peroxide Gel, 26 weeks",{"trials":731,"activeCount":95},[],{"intervention":729,"totalTrials":111,"cells":733},{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":740,"PHASE4":742,"NA":748},{"trials":735,"activeCount":95},[],{"trials":737,"activeCount":95},[],{"trials":739,"activeCount":95},[],{"trials":741,"activeCount":95},[],{"trials":743,"activeCount":95},[744],{"nctId":720,"briefTitle":721,"status":135,"phases":745,"primaryCompletion":723,"completion":723,"start":724,"enrollment":725,"conditions":746,"interventions":747},[88],[727],[707,729],{"trials":749,"activeCount":95},[],{"intervention":751,"totalTrials":111,"cells":752},"Lomaira 8Mg",{"EARLY_PHASE1":753,"PHASE1":755,"PHASE2":757,"PHASE3":759,"PHASE4":761,"NA":774},{"trials":754,"activeCount":95},[],{"trials":756,"activeCount":95},[],{"trials":758,"activeCount":95},[],{"trials":760,"activeCount":95},[],{"trials":762,"activeCount":95},[763],{"nctId":764,"briefTitle":765,"status":395,"phases":766,"primaryCompletion":767,"completion":768,"start":769,"enrollment":95,"conditions":770,"interventions":773},"NCT06768320","Treating Toddler Obesity by Treating the Parent\u002FCaregiver Obesity With Weight Loss Medications",[88],"2027-01","2027-11","2025-12",[771,772,15],"Weight Loss","Obesity, Childhood",[751],{"trials":775,"activeCount":95},[],{"intervention":777,"totalTrials":111,"cells":778},"Regimen 1",{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":785,"PHASE4":801,"NA":803},{"trials":780,"activeCount":95},[],{"trials":782,"activeCount":95},[],{"trials":784,"activeCount":95},[],{"trials":786,"activeCount":95},[787],{"nctId":788,"briefTitle":789,"status":242,"phases":790,"primaryCompletion":791,"completion":792,"start":793,"enrollment":794,"conditions":795,"interventions":798},"NCT05126459","A Comparison of Oral Sedation-related Events of Three Multiagent Oral Sedation Regimens in Pediatric Dental Patients",[87],"2023-04-11","2023-04-12","2022-02-14",60,[796,797],"Anxiety, Dental","Dental Decay",[777,799,800],"Regimen #2","Regimen #3",{"trials":802,"activeCount":95},[],{"trials":804,"activeCount":95},[],{"intervention":799,"totalTrials":111,"cells":806},{"EARLY_PHASE1":807,"PHASE1":809,"PHASE2":811,"PHASE3":813,"PHASE4":819,"NA":821},{"trials":808,"activeCount":95},[],{"trials":810,"activeCount":95},[],{"trials":812,"activeCount":95},[],{"trials":814,"activeCount":95},[815],{"nctId":788,"briefTitle":789,"status":242,"phases":816,"primaryCompletion":791,"completion":792,"start":793,"enrollment":794,"conditions":817,"interventions":818},[87],[796,797],[777,799,800],{"trials":820,"activeCount":95},[],{"trials":822,"activeCount":95},[],{"intervention":800,"totalTrials":111,"cells":824},{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":837,"NA":839},{"trials":826,"activeCount":95},[],{"trials":828,"activeCount":95},[],{"trials":830,"activeCount":95},[],{"trials":832,"activeCount":95},[833],{"nctId":788,"briefTitle":789,"status":242,"phases":834,"primaryCompletion":791,"completion":792,"start":793,"enrollment":794,"conditions":835,"interventions":836},[87],[796,797],[777,799,800],{"trials":838,"activeCount":95},[],{"trials":840,"activeCount":95},[],{"intervention":842,"totalTrials":111,"cells":843},"Norco",{"EARLY_PHASE1":844,"PHASE1":846,"PHASE2":848,"PHASE3":850,"PHASE4":863,"NA":865},{"trials":845,"activeCount":95},[],{"trials":847,"activeCount":95},[],{"trials":849,"activeCount":95},[],{"trials":851,"activeCount":95},[852],{"nctId":853,"briefTitle":854,"status":242,"phases":855,"primaryCompletion":856,"completion":856,"start":857,"enrollment":858,"conditions":859,"interventions":861},"NCT03404518","Patient Narcotic Requirements After Outpatient Otolaryngology Procedures",[87],"2018-10-01","2018-02-21",185,[860,184],"Outpatient Surgery",[842,862],"Ibuprofen",{"trials":864,"activeCount":95},[],{"trials":866,"activeCount":95},[],{"intervention":862,"totalTrials":111,"cells":868},{"EARLY_PHASE1":869,"PHASE1":871,"PHASE2":873,"PHASE3":875,"PHASE4":881,"NA":883},{"trials":870,"activeCount":95},[],{"trials":872,"activeCount":95},[],{"trials":874,"activeCount":95},[],{"trials":876,"activeCount":95},[877],{"nctId":853,"briefTitle":854,"status":242,"phases":878,"primaryCompletion":856,"completion":856,"start":857,"enrollment":858,"conditions":879,"interventions":880},[87],[860,184],[842,862],{"trials":882,"activeCount":95},[],{"trials":884,"activeCount":95},[],{"intervention":886,"totalTrials":111,"cells":887},"zolpidem",{"EARLY_PHASE1":888,"PHASE1":890,"PHASE2":892,"PHASE3":894,"PHASE4":908,"NA":910},{"trials":889,"activeCount":95},[],{"trials":891,"activeCount":95},[],{"trials":893,"activeCount":95},[],{"trials":895,"activeCount":95},[896],{"nctId":897,"briefTitle":898,"status":242,"phases":899,"primaryCompletion":900,"completion":900,"start":901,"enrollment":902,"conditions":903,"interventions":906},"NCT02096900","A Comparison of Midazolam and Zolpidem as Oral Premedication in Children",[87],"2016-05-06","2014-07-21",86,[904,905],"Parental\u002FCaregiver Anxiety","Child's Anxiety",[886,907],"Midazolam",{"trials":909,"activeCount":95},[],{"trials":911,"activeCount":95},[],{"intervention":907,"totalTrials":111,"cells":913},{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":920,"PHASE4":926,"NA":928},{"trials":915,"activeCount":95},[],{"trials":917,"activeCount":95},[],{"trials":919,"activeCount":95},[],{"trials":921,"activeCount":95},[922],{"nctId":897,"briefTitle":898,"status":242,"phases":923,"primaryCompletion":900,"completion":900,"start":901,"enrollment":902,"conditions":924,"interventions":925},[87],[904,905],[886,907],{"trials":927,"activeCount":95},[],{"trials":929,"activeCount":95},[],{"intervention":931,"totalTrials":111,"cells":932},"Diclofenac 1% Topical",{"EARLY_PHASE1":933,"PHASE1":935,"PHASE2":937,"PHASE3":939,"PHASE4":950,"NA":952},{"trials":934,"activeCount":95},[],{"trials":936,"activeCount":95},[],{"trials":938,"activeCount":95},[],{"trials":940,"activeCount":95},[941],{"nctId":942,"briefTitle":943,"status":395,"phases":944,"primaryCompletion":945,"completion":945,"start":946,"enrollment":95,"conditions":947,"interventions":949},"NCT05312645","Diclofenac Gel in the Treatment of Cervicogenic Headache",[87],"2024-08-21","2023-12",[948],"Cervicogenic Headache",[931],{"trials":951,"activeCount":95},[],{"trials":953,"activeCount":95},[],{"intervention":955,"totalTrials":111,"cells":956},"Routine labs",{"EARLY_PHASE1":957,"PHASE1":959,"PHASE2":961,"PHASE3":963,"PHASE4":977,"NA":979},{"trials":958,"activeCount":95},[],{"trials":960,"activeCount":95},[],{"trials":962,"activeCount":95},[],{"trials":964,"activeCount":95},[965],{"nctId":966,"briefTitle":967,"status":242,"phases":968,"primaryCompletion":969,"completion":969,"start":970,"enrollment":971,"conditions":972,"interventions":976},"NCT05081063","Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients",[87],"2023-05-15","2022-03-05",199,[973,974,975],"Hemorrhagic Shock","Acute Blood Loss Anemia","Traumatic Brain Injury",[955],{"trials":978,"activeCount":95},[],{"trials":980,"activeCount":95},[],{"intervention":982,"totalTrials":111,"cells":983},"Liposomal Bupivicaine",{"EARLY_PHASE1":984,"PHASE1":986,"PHASE2":988,"PHASE3":990,"PHASE4":1000,"NA":1002},{"trials":985,"activeCount":95},[],{"trials":987,"activeCount":95},[],{"trials":989,"activeCount":95},[],{"trials":991,"activeCount":95},[992],{"nctId":993,"briefTitle":994,"status":395,"phases":995,"primaryCompletion":996,"completion":996,"start":997,"enrollment":95,"conditions":998,"interventions":999},"NCT02933814","Liposomal Bupivacaine in Ambulatory Hand Surgery",[87],"2019-02","2018-02-09",[24],[982],{"trials":1001,"activeCount":95},[],{"trials":1003,"activeCount":95},[],{"intervention":1005,"totalTrials":111,"cells":1006},"Semaglutide 2.4mg",{"EARLY_PHASE1":1007,"PHASE1":1009,"PHASE2":1011,"PHASE3":1013,"PHASE4":1028,"NA":1030},{"trials":1008,"activeCount":95},[],{"trials":1010,"activeCount":95},[],{"trials":1012,"activeCount":95},[],{"trials":1014,"activeCount":95},[1015],{"nctId":1016,"briefTitle":1017,"status":242,"phases":1018,"primaryCompletion":1019,"completion":1019,"start":1020,"enrollment":1021,"conditions":1022,"interventions":1027},"NCT05087342","Latino Semaglutide Study",[87],"2024-05-29","2022-12-13",119,[15,1023,1024,771,1025,1026],"Obesity; Drug","Overweight or Obesity","Weight Loss Trajectory","Weight, Body",[1005],{"trials":1029,"activeCount":95},[],{"trials":1031,"activeCount":95},[],{"intervention":1033,"totalTrials":111,"cells":1034},"Hypochlorous Acid Gel 0.02%",{"EARLY_PHASE1":1035,"PHASE1":1037,"PHASE2":1039,"PHASE3":1041,"PHASE4":1054,"NA":1056},{"trials":1036,"activeCount":95},[],{"trials":1038,"activeCount":95},[],{"trials":1040,"activeCount":95},[],{"trials":1042,"activeCount":95},[1043],{"nctId":1044,"briefTitle":1045,"status":242,"phases":1046,"primaryCompletion":1047,"completion":1047,"start":1048,"enrollment":1049,"conditions":1050,"interventions":1053},"NCT04568213","Hypochlorous Acid Disinfection Prior to Cataract Surgery",[87],"2022-12-09","2020-10-29",54,[1051,1052],"Cataract","Endophthalmitis",[1033],{"trials":1055,"activeCount":95},[],{"trials":1057,"activeCount":95},[],{"intervention":1059,"totalTrials":229,"cells":1060},"Carboplatin",{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1074,"PHASE3":1087,"PHASE4":1089,"NA":1091},{"trials":1062,"activeCount":95},[],{"trials":1064,"activeCount":95},[1065],{"nctId":1066,"briefTitle":1067,"status":242,"phases":1068,"primaryCompletion":1069,"completion":1069,"start":1070,"enrollment":384,"conditions":1071,"interventions":1073},"NCT02672098","Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer",[85],"2023-04-19","2016-07-14",[1072],"Ovarian Cancer",[1059],{"trials":1075,"activeCount":95},[1076],{"nctId":1077,"briefTitle":1078,"status":135,"phases":1079,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":1082,"conditions":1083,"interventions":1085},"NCT00614484","Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer",[85,86],"2011-06","1999-08",28,[1084],"Locally Advanced Non-Small Cell Lung Cancer",[1086,1059],"Taxol",{"trials":1088,"activeCount":95},[],{"trials":1090,"activeCount":95},[],{"trials":1092,"activeCount":95},[],{"intervention":1094,"totalTrials":111,"cells":1095},"Interleukin-2",{"EARLY_PHASE1":1096,"PHASE1":1098,"PHASE2":1100,"PHASE3":1112,"PHASE4":1114,"NA":1116},{"trials":1097,"activeCount":95},[],{"trials":1099,"activeCount":95},[],{"trials":1101,"activeCount":95},[1102],{"nctId":1103,"briefTitle":1104,"status":395,"phases":1105,"primaryCompletion":1106,"completion":1106,"start":1107,"enrollment":95,"conditions":1108,"interventions":1111},"NCT01355562","Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer",[86],"2012-02","2011-03",[1109,1110],"Melanoma","Metastatic Kidney Cancer",[1094],{"trials":1113,"activeCount":95},[],{"trials":1115,"activeCount":95},[],{"trials":1117,"activeCount":95},[],{"intervention":1119,"totalTrials":111,"cells":1120},"Tazemetostat",{"EARLY_PHASE1":1121,"PHASE1":1123,"PHASE2":1125,"PHASE3":1137,"PHASE4":1139,"NA":1141},{"trials":1122,"activeCount":95},[],{"trials":1124,"activeCount":95},[],{"trials":1126,"activeCount":95},[1127],{"nctId":1128,"briefTitle":1129,"status":395,"phases":1130,"primaryCompletion":1131,"completion":1131,"start":1132,"enrollment":95,"conditions":1133,"interventions":1136},"NCT05018975","Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection",[86],"2023-09-21","2022-01",[1134,1135],"COVID-19 Acute Respiratory Distress Syndrome","Cytokine Release Syndrome",[1119],{"trials":1138,"activeCount":95},[],{"trials":1140,"activeCount":95},[],{"trials":1142,"activeCount":95},[],{"intervention":1144,"totalTrials":111,"cells":1145},"PET\u002FCT with F-Fluciclovine",{"EARLY_PHASE1":1146,"PHASE1":1148,"PHASE2":1150,"PHASE3":1161,"PHASE4":1163,"NA":1165},{"trials":1147,"activeCount":95},[],{"trials":1149,"activeCount":95},[],{"trials":1151,"activeCount":95},[1152],{"nctId":1153,"briefTitle":1154,"status":395,"phases":1155,"primaryCompletion":1156,"completion":1156,"start":1157,"enrollment":95,"conditions":1158,"interventions":1160},"NCT03925675","18F-Fluciclovine PET and Multiparametric MR Imaging",[86],"2023-08-31","2020-08-24",[1159],"Brain Tumor, Recurrent, Adult",[1144],{"trials":1162,"activeCount":95},[],{"trials":1164,"activeCount":95},[],{"trials":1166,"activeCount":95},[],{"intervention":1168,"totalTrials":111,"cells":1169},"Nitric Oxide",{"EARLY_PHASE1":1170,"PHASE1":1172,"PHASE2":1174,"PHASE3":1186,"PHASE4":1188,"NA":1190},{"trials":1171,"activeCount":95},[],{"trials":1173,"activeCount":95},[],{"trials":1175,"activeCount":95},[1176],{"nctId":1177,"briefTitle":1178,"status":135,"phases":1179,"primaryCompletion":1180,"completion":1180,"start":1181,"enrollment":1182,"conditions":1183,"interventions":1185},"NCT00823095","Topical Nitric Oxide Trial in Chronic Non-Healing Wounds",[86],"2008-10","2005-12",7,[1184],"Chronic Ulcer of Lower Extremity",[1168],{"trials":1187,"activeCount":95},[],{"trials":1189,"activeCount":95},[],{"trials":1191,"activeCount":95},[],{"intervention":1193,"totalTrials":111,"cells":1194},"Droxidopa",{"EARLY_PHASE1":1195,"PHASE1":1197,"PHASE2":1199,"PHASE3":1212,"PHASE4":1214,"NA":1216},{"trials":1196,"activeCount":95},[],{"trials":1198,"activeCount":95},[],{"trials":1200,"activeCount":95},[1201],{"nctId":1202,"briefTitle":1203,"status":395,"phases":1204,"primaryCompletion":1205,"completion":1205,"start":1206,"enrollment":95,"conditions":1207,"interventions":1211},"NCT03446807","Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism",[86],"2023-07-01","2021-12",[1208,1209,1210],"Parkinson Disease","Multiple System Atrophy","Progressive Supranuclear Palsy",[1193],{"trials":1213,"activeCount":95},[],{"trials":1215,"activeCount":95},[],{"trials":1217,"activeCount":95},[],{"intervention":1219,"totalTrials":111,"cells":1220},"sildenafil",{"EARLY_PHASE1":1221,"PHASE1":1223,"PHASE2":1225,"PHASE3":1236,"PHASE4":1238,"NA":1240},{"trials":1222,"activeCount":95},[],{"trials":1224,"activeCount":95},[],{"trials":1226,"activeCount":95},[1227],{"nctId":1228,"briefTitle":1229,"status":135,"phases":1230,"primaryCompletion":1231,"completion":1231,"start":1232,"enrollment":229,"conditions":1233,"interventions":1235},"NCT02162979","Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease",[86],"2009-01","2002-02",[1234],"Parkinson's Disease",[1219],{"trials":1237,"activeCount":95},[],{"trials":1239,"activeCount":95},[],{"trials":1241,"activeCount":95},[],{"intervention":1243,"totalTrials":111,"cells":1244},"Furosemide",{"EARLY_PHASE1":1245,"PHASE1":1247,"PHASE2":1249,"PHASE3":1260,"PHASE4":1262,"NA":1264},{"trials":1246,"activeCount":95},[],{"trials":1248,"activeCount":95},[],{"trials":1250,"activeCount":95},[1251],{"nctId":1252,"briefTitle":1253,"status":395,"phases":1254,"primaryCompletion":1255,"completion":1255,"start":1256,"enrollment":95,"conditions":1257,"interventions":1259},"NCT02312115","Delayed Renal Allograft Function and Furosemide Treatment",[86],"2016-10","2016-09",[1258],"Delayed Graft Function",[1243],{"trials":1261,"activeCount":95},[],{"trials":1263,"activeCount":95},[],{"trials":1265,"activeCount":95},[],{"intervention":1267,"totalTrials":111,"cells":1268},"Curcumin",{"EARLY_PHASE1":1269,"PHASE1":1271,"PHASE2":1273,"PHASE3":1284,"PHASE4":1286,"NA":1288},{"trials":1270,"activeCount":95},[],{"trials":1272,"activeCount":95},[],{"trials":1274,"activeCount":95},[1275],{"nctId":1276,"briefTitle":1277,"status":395,"phases":1278,"primaryCompletion":1279,"completion":1279,"start":1280,"enrollment":95,"conditions":1281,"interventions":1283},"NCT04353310","Evaluating Effects of Curcumin in Moderate to Severe Asthmatics",[86],"2021-11-09","2021-09",[1282],"Asthma",[1267],{"trials":1285,"activeCount":95},[],{"trials":1287,"activeCount":95},[],{"trials":1289,"activeCount":95},[],{"intervention":1291,"totalTrials":111,"cells":1292},"Curcumin supplement",{"EARLY_PHASE1":1293,"PHASE1":1295,"PHASE2":1297,"PHASE3":1308,"PHASE4":1310,"NA":1312},{"trials":1294,"activeCount":95},[],{"trials":1296,"activeCount":95},[],{"trials":1298,"activeCount":95},[1299],{"nctId":1300,"briefTitle":1301,"status":135,"phases":1302,"primaryCompletion":1303,"completion":1303,"start":1304,"enrollment":1305,"conditions":1306,"interventions":1307},"NCT03953261","Effect of Curcumin on Systemic Lupus Erythematosus",[86],"2022-04-13","2019-09-01",23,[549],[1291],{"trials":1309,"activeCount":95},[],{"trials":1311,"activeCount":95},[],{"trials":1313,"activeCount":95},[],{"intervention":1086,"totalTrials":111,"cells":1315},{"EARLY_PHASE1":1316,"PHASE1":1318,"PHASE2":1320,"PHASE3":1326,"PHASE4":1328,"NA":1330},{"trials":1317,"activeCount":95},[],{"trials":1319,"activeCount":95},[],{"trials":1321,"activeCount":95},[1322],{"nctId":1077,"briefTitle":1078,"status":135,"phases":1323,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":1082,"conditions":1324,"interventions":1325},[85,86],[1084],[1086,1059],{"trials":1327,"activeCount":95},[],{"trials":1329,"activeCount":95},[],{"trials":1331,"activeCount":95},[],{"intervention":1333,"totalTrials":111,"cells":1334},"Azacitidine and Cisplatin",{"EARLY_PHASE1":1335,"PHASE1":1337,"PHASE2":1349,"PHASE3":1351,"PHASE4":1353,"NA":1355},{"trials":1336,"activeCount":95},[],{"trials":1338,"activeCount":95},[1339],{"nctId":1340,"briefTitle":1341,"status":135,"phases":1342,"primaryCompletion":1343,"completion":547,"start":1344,"enrollment":19,"conditions":1345,"interventions":1348},"NCT00901537","Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer",[85],"2011-09","2009-02",[1346,1347],"Non-small Cell Lung Cancer","Squamous Cell Carcinoma of the Head and Neck",[1333],{"trials":1350,"activeCount":95},[],{"trials":1352,"activeCount":95},[],{"trials":1354,"activeCount":95},[],{"trials":1356,"activeCount":95},[],{"intervention":1358,"totalTrials":111,"cells":1359},"iloprost",{"EARLY_PHASE1":1360,"PHASE1":1362,"PHASE2":1372,"PHASE3":1374,"PHASE4":1376,"NA":1378},{"trials":1361,"activeCount":95},[],{"trials":1363,"activeCount":95},[1364],{"nctId":1365,"briefTitle":1366,"status":395,"phases":1367,"primaryCompletion":1368,"completion":1368,"start":412,"enrollment":95,"conditions":1369,"interventions":1371},"NCT00724321","Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude",[85],"2008-11",[1370],"Hypoxic Pulmonary Vasoconstriction",[1358],{"trials":1373,"activeCount":95},[],{"trials":1375,"activeCount":95},[],{"trials":1377,"activeCount":95},[],{"trials":1379,"activeCount":95},[],{"intervention":1381,"totalTrials":111,"cells":1382},"Hyperthermic Intraperitoneal Chemotherapy",{"EARLY_PHASE1":1383,"PHASE1":1385,"PHASE2":1397,"PHASE3":1399,"PHASE4":1401,"NA":1403},{"trials":1384,"activeCount":95},[],{"trials":1386,"activeCount":95},[1387],{"nctId":1388,"briefTitle":1389,"status":242,"phases":1390,"primaryCompletion":1391,"completion":1391,"start":1392,"enrollment":30,"conditions":1393,"interventions":1396},"NCT02672865","Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer",[85],"2018-10-03","2016-02-02",[1394,1395],"Locally Advanced Malignant Neoplasm","Gastric Cancer",[1381],{"trials":1398,"activeCount":95},[],{"trials":1400,"activeCount":95},[],{"trials":1402,"activeCount":95},[],{"trials":1404,"activeCount":95},[],{"intervention":1406,"totalTrials":111,"cells":1407},"corticosteroid solution with lidocaine containing parabens.",{"EARLY_PHASE1":1408,"PHASE1":1421,"PHASE2":1423,"PHASE3":1425,"PHASE4":1427,"NA":1429},{"trials":1409,"activeCount":95},[1410],{"nctId":1411,"briefTitle":1412,"status":395,"phases":1413,"primaryCompletion":1414,"completion":1415,"start":1416,"enrollment":95,"conditions":1417,"interventions":1419},"NCT03445611","Parabens Flocculation on the Anti Inflammatory Effects of Corticosteroid Injections for Total Knee Arthroplasty",[84],"2019-10-15","2019-10-30","2019-09-15",[1418],"Osteoarthritis, Knee",[1406,1420],"corticosteroid solution with lidocaine containing no paraben",{"trials":1422,"activeCount":95},[],{"trials":1424,"activeCount":95},[],{"trials":1426,"activeCount":95},[],{"trials":1428,"activeCount":95},[],{"trials":1430,"activeCount":95},[],{"intervention":1420,"totalTrials":111,"cells":1432},{"EARLY_PHASE1":1433,"PHASE1":1439,"PHASE2":1441,"PHASE3":1443,"PHASE4":1445,"NA":1447},{"trials":1434,"activeCount":95},[1435],{"nctId":1411,"briefTitle":1412,"status":395,"phases":1436,"primaryCompletion":1414,"completion":1415,"start":1416,"enrollment":95,"conditions":1437,"interventions":1438},[84],[1418],[1406,1420],{"trials":1440,"activeCount":95},[],{"trials":1442,"activeCount":95},[],{"trials":1444,"activeCount":95},[],{"trials":1446,"activeCount":95},[],{"trials":1448,"activeCount":95},[],{"intervention":1450,"totalTrials":111,"cells":1451},"hydrocodone \u002F acetaminophen 5mg\u002F325mg",{"EARLY_PHASE1":1452,"PHASE1":1463,"PHASE2":1465,"PHASE3":1467,"PHASE4":1469,"NA":1471},{"trials":1453,"activeCount":95},[1454],{"nctId":1455,"briefTitle":1456,"status":395,"phases":1457,"primaryCompletion":1458,"completion":1458,"start":1459,"enrollment":95,"conditions":1460,"interventions":1462},"NCT02540512","Acupuncture for Pain in the Emergency Department",[84],"2017-09","2017-07-27",[1461,24],"Musculoskeletal Pain",[1450],{"trials":1464,"activeCount":95},[],{"trials":1466,"activeCount":95},[],{"trials":1468,"activeCount":95},[],{"trials":1470,"activeCount":95},[],{"trials":1472,"activeCount":95},[],{"intervention":1474,"totalTrials":384,"cells":1475},"corticosteroid",{"EARLY_PHASE1":1476,"PHASE1":1478,"PHASE2":1480,"PHASE3":1482,"PHASE4":1484,"NA":1496},{"trials":1477,"activeCount":95},[],{"trials":1479,"activeCount":95},[],{"trials":1481,"activeCount":95},[],{"trials":1483,"activeCount":95},[],{"trials":1485,"activeCount":95},[1486],{"nctId":1487,"briefTitle":1488,"status":395,"phases":1489,"primaryCompletion":1490,"completion":1490,"start":1491,"enrollment":95,"conditions":1492,"interventions":1494},"NCT03032432","A Dynamic Elastic Garment (DEG) in Patients With Rotator Cuff Tendinopathy",[88],"2019-02-15","2018-06-12",[1493],"Rotator Cuff Tendinopathy",[1495],"Corticosteroid",{"trials":1497,"activeCount":95},[1498,1507],{"nctId":1499,"briefTitle":1500,"status":395,"phases":1501,"primaryCompletion":138,"completion":138,"start":1502,"enrollment":95,"conditions":1503,"interventions":1505},"NCT01127672","Treatment of Plantar Fasciitis With Platelet Rich Plasma",[89],"2010-05",[1504],"Plantar Fasciitis",[1506,1474],"platelet rich plasma",{"nctId":1508,"briefTitle":1509,"status":242,"phases":1510,"primaryCompletion":138,"completion":138,"start":1502,"enrollment":1511,"conditions":1512,"interventions":1515},"NCT01123889","Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection",[89],12,[1513,1514],"Subacromial Impingement Syndrome","Partial Thickness Rotator Cuff Tear",[1506,1474],{"intervention":1517,"totalTrials":229,"cells":1518},"Liposomal bupivacaine",{"EARLY_PHASE1":1519,"PHASE1":1521,"PHASE2":1523,"PHASE3":1525,"PHASE4":1527,"NA":1540},{"trials":1520,"activeCount":95},[],{"trials":1522,"activeCount":95},[],{"trials":1524,"activeCount":95},[],{"trials":1526,"activeCount":95},[],{"trials":1528,"activeCount":95},[1529],{"nctId":1530,"briefTitle":1531,"status":135,"phases":1532,"primaryCompletion":1533,"completion":1533,"start":1534,"enrollment":1182,"conditions":1535,"interventions":1539},"NCT04360421","Use of Long-acting Bupivacaine In Lower Extremity Amputation",[88],"2023-08-01","2020-04-21",[1536,1537,1538],"Amputation","Anesthesia, Local","Opioid Use",[1517],{"trials":1541,"activeCount":95},[1542],{"nctId":1543,"briefTitle":1544,"status":135,"phases":1545,"primaryCompletion":1256,"completion":1546,"start":1547,"enrollment":1548,"conditions":1549,"interventions":1551},"NCT02659501","Liposomal Bupivacaine in Implant Based Breast Reconstruction",[89],"2017-07","2015-07",24,[1550,32],"Breast Cancer",[1517,1552,1553,1554,1555],"Bupivacaine with epinephrine","Morphine sulfate","Hydrocodone\u002Facetaminophen","Diazepam",{"intervention":144,"totalTrials":229,"cells":1557},{"EARLY_PHASE1":1558,"PHASE1":1560,"PHASE2":1562,"PHASE3":1564,"PHASE4":1566,"NA":1568},{"trials":1559,"activeCount":95},[],{"trials":1561,"activeCount":95},[],{"trials":1563,"activeCount":95},[],{"trials":1565,"activeCount":95},[],{"trials":1567,"activeCount":95},[],{"trials":1569,"activeCount":95},[1570,1574],{"nctId":133,"briefTitle":134,"status":135,"phases":1571,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":1572,"interventions":1573},[89],[142],[144,145,145,54],{"nctId":1575,"briefTitle":1576,"status":135,"phases":1577,"primaryCompletion":1578,"completion":1578,"start":414,"enrollment":1579,"conditions":1580,"interventions":1583},"NCT00616577","Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine",[89],"2010-09",26,[1581,1582],"Inguinal Herniorrhaphy","Orchiopexy",[144,144,144],{"intervention":145,"totalTrials":229,"cells":1585},{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1592,"PHASE4":1604,"NA":1606},{"trials":1587,"activeCount":95},[],{"trials":1589,"activeCount":95},[],{"trials":1591,"activeCount":95},[],{"trials":1593,"activeCount":95},[1594],{"nctId":1595,"briefTitle":1596,"status":242,"phases":1597,"primaryCompletion":1598,"completion":1598,"start":1599,"enrollment":1600,"conditions":1601,"interventions":1603},"NCT03598426","Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity",[87],"2025-01-07","2018-08-08",90,[1602],"Hypersensitivity Reactions",[145],{"trials":1605,"activeCount":95},[],{"trials":1607,"activeCount":95},[1608],{"nctId":133,"briefTitle":134,"status":135,"phases":1609,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":1610,"interventions":1611},[89],[142],[144,145,145,54],{"intervention":1506,"totalTrials":229,"cells":1613},{"EARLY_PHASE1":1614,"PHASE1":1616,"PHASE2":1618,"PHASE3":1620,"PHASE4":1622,"NA":1624},{"trials":1615,"activeCount":95},[],{"trials":1617,"activeCount":95},[],{"trials":1619,"activeCount":95},[],{"trials":1621,"activeCount":95},[],{"trials":1623,"activeCount":95},[],{"trials":1625,"activeCount":95},[1626,1630],{"nctId":1499,"briefTitle":1500,"status":395,"phases":1627,"primaryCompletion":138,"completion":138,"start":1502,"enrollment":95,"conditions":1628,"interventions":1629},[89],[1504],[1506,1474],{"nctId":1508,"briefTitle":1509,"status":242,"phases":1631,"primaryCompletion":138,"completion":138,"start":1502,"enrollment":1511,"conditions":1632,"interventions":1633},[89],[1513,1514],[1506,1474],{"intervention":1635,"totalTrials":111,"cells":1636},"6 day Prednisone",{"EARLY_PHASE1":1637,"PHASE1":1639,"PHASE2":1641,"PHASE3":1643,"PHASE4":1645,"NA":1647},{"trials":1638,"activeCount":95},[],{"trials":1640,"activeCount":95},[],{"trials":1642,"activeCount":95},[],{"trials":1644,"activeCount":95},[],{"trials":1646,"activeCount":95},[],{"trials":1648,"activeCount":95},[1649],{"nctId":1650,"briefTitle":1651,"status":242,"phases":1652,"primaryCompletion":1653,"completion":1654,"start":1655,"enrollment":1548,"conditions":1656,"interventions":1658},"NCT02927834","Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps",[89],"2018-12","2019-01","2015-08",[1657],"Sinusitis",[1635,1659,1660],"Augmentin","21 day Prednisone",{"intervention":1659,"totalTrials":111,"cells":1662},{"EARLY_PHASE1":1663,"PHASE1":1665,"PHASE2":1667,"PHASE3":1669,"PHASE4":1671,"NA":1673},{"trials":1664,"activeCount":95},[],{"trials":1666,"activeCount":95},[],{"trials":1668,"activeCount":95},[],{"trials":1670,"activeCount":95},[],{"trials":1672,"activeCount":95},[],{"trials":1674,"activeCount":95},[1675],{"nctId":1650,"briefTitle":1651,"status":242,"phases":1676,"primaryCompletion":1653,"completion":1654,"start":1655,"enrollment":1548,"conditions":1677,"interventions":1678},[89],[1657],[1635,1659,1660],{"intervention":1660,"totalTrials":111,"cells":1680},{"EARLY_PHASE1":1681,"PHASE1":1683,"PHASE2":1685,"PHASE3":1687,"PHASE4":1689,"NA":1691},{"trials":1682,"activeCount":95},[],{"trials":1684,"activeCount":95},[],{"trials":1686,"activeCount":95},[],{"trials":1688,"activeCount":95},[],{"trials":1690,"activeCount":95},[],{"trials":1692,"activeCount":95},[1693],{"nctId":1650,"briefTitle":1651,"status":242,"phases":1694,"primaryCompletion":1653,"completion":1654,"start":1655,"enrollment":1548,"conditions":1695,"interventions":1696},[89],[1657],[1635,1659,1660],{"intervention":1698,"totalTrials":111,"cells":1699},"Gabapentin",{"EARLY_PHASE1":1700,"PHASE1":1702,"PHASE2":1704,"PHASE3":1706,"PHASE4":1708,"NA":1710},{"trials":1701,"activeCount":95},[],{"trials":1703,"activeCount":95},[],{"trials":1705,"activeCount":95},[],{"trials":1707,"activeCount":95},[],{"trials":1709,"activeCount":95},[],{"trials":1711,"activeCount":95},[1712],{"nctId":1713,"briefTitle":1714,"status":135,"phases":1715,"primaryCompletion":1716,"completion":1717,"start":1718,"enrollment":19,"conditions":1719,"interventions":1720},"NCT00954187","Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy",[89],"2012-09","2013-04","2009-11",[32],[1698,1721],"pregabalin",{"intervention":1721,"totalTrials":111,"cells":1723},{"EARLY_PHASE1":1724,"PHASE1":1726,"PHASE2":1728,"PHASE3":1730,"PHASE4":1732,"NA":1734},{"trials":1725,"activeCount":95},[],{"trials":1727,"activeCount":95},[],{"trials":1729,"activeCount":95},[],{"trials":1731,"activeCount":95},[],{"trials":1733,"activeCount":95},[],{"trials":1735,"activeCount":95},[1736],{"nctId":1713,"briefTitle":1714,"status":135,"phases":1737,"primaryCompletion":1716,"completion":1717,"start":1718,"enrollment":19,"conditions":1738,"interventions":1739},[89],[32],[1698,1721],{"intervention":1741,"totalTrials":111,"cells":1742},"Morphine PCA started at the end of surgery, 1 Percocet 1\u002F325mg every 4 hours; may receive a second Percocet if needed.",{"EARLY_PHASE1":1743,"PHASE1":1745,"PHASE2":1747,"PHASE3":1749,"PHASE4":1751,"NA":1753},{"trials":1744,"activeCount":95},[],{"trials":1746,"activeCount":95},[],{"trials":1748,"activeCount":95},[],{"trials":1750,"activeCount":95},[],{"trials":1752,"activeCount":95},[],{"trials":1754,"activeCount":95},[1755],{"nctId":1756,"briefTitle":1757,"status":395,"phases":1758,"primaryCompletion":1759,"completion":1759,"start":1760,"enrollment":95,"conditions":1761,"interventions":1763},"NCT01939379","Adductor Canal Nerve Block Following Total Knee Arthroplasty",[89],"2017-07-25","2013-09",[1762],"Post-op Pain",[1741,1764],"For the 30ml ropivacaine the intervention would be the subject can request extra pain medication which would be Percocet and\u002For morphine PCA.",{"intervention":1764,"totalTrials":111,"cells":1766},{"EARLY_PHASE1":1767,"PHASE1":1769,"PHASE2":1771,"PHASE3":1773,"PHASE4":1775,"NA":1777},{"trials":1768,"activeCount":95},[],{"trials":1770,"activeCount":95},[],{"trials":1772,"activeCount":95},[],{"trials":1774,"activeCount":95},[],{"trials":1776,"activeCount":95},[],{"trials":1778,"activeCount":95},[1779],{"nctId":1756,"briefTitle":1757,"status":395,"phases":1780,"primaryCompletion":1759,"completion":1759,"start":1760,"enrollment":95,"conditions":1781,"interventions":1782},[89],[1762],[1741,1764],{"intervention":1784,"totalTrials":111,"cells":1785},"Thiamine",{"EARLY_PHASE1":1786,"PHASE1":1788,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1796},{"trials":1787,"activeCount":95},[],{"trials":1789,"activeCount":95},[],{"trials":1791,"activeCount":95},[],{"trials":1793,"activeCount":95},[],{"trials":1795,"activeCount":95},[],{"trials":1797,"activeCount":95},[1798],{"nctId":1799,"briefTitle":1800,"status":395,"phases":1801,"primaryCompletion":1802,"completion":1802,"start":1803,"enrollment":95,"conditions":1804,"interventions":1808},"NCT00279266","Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy",[89],"2006-06","2006-01",[1805,1806,1807],"Peripheral Neuropathy","Diabetes Mellitus","Diabetes Complications",[1784],{"intervention":1810,"totalTrials":111,"cells":1811},"Tranexamic Acid",{"EARLY_PHASE1":1812,"PHASE1":1814,"PHASE2":1816,"PHASE3":1818,"PHASE4":1820,"NA":1822},{"trials":1813,"activeCount":95},[],{"trials":1815,"activeCount":95},[],{"trials":1817,"activeCount":95},[],{"trials":1819,"activeCount":95},[],{"trials":1821,"activeCount":95},[],{"trials":1823,"activeCount":95},[1824],{"nctId":1825,"briefTitle":1826,"status":242,"phases":1827,"primaryCompletion":635,"completion":1828,"start":1829,"enrollment":222,"conditions":1830,"interventions":1832},"NCT01248104","Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery",[89],"2015-02","2010-03",[1831],"Cardiopulmonary Bypass",[1810,1833],"Aminocaproic Acid",{"intervention":1833,"totalTrials":111,"cells":1835},{"EARLY_PHASE1":1836,"PHASE1":1838,"PHASE2":1840,"PHASE3":1842,"PHASE4":1844,"NA":1846},{"trials":1837,"activeCount":95},[],{"trials":1839,"activeCount":95},[],{"trials":1841,"activeCount":95},[],{"trials":1843,"activeCount":95},[],{"trials":1845,"activeCount":95},[],{"trials":1847,"activeCount":95},[1848],{"nctId":1825,"briefTitle":1826,"status":242,"phases":1849,"primaryCompletion":635,"completion":1828,"start":1829,"enrollment":222,"conditions":1850,"interventions":1851},[89],[1831],[1810,1833],{"intervention":1853,"totalTrials":111,"cells":1854},"4% prilocaine plain",{"EARLY_PHASE1":1855,"PHASE1":1857,"PHASE2":1859,"PHASE3":1861,"PHASE4":1863,"NA":1865},{"trials":1856,"activeCount":95},[],{"trials":1858,"activeCount":95},[],{"trials":1860,"activeCount":95},[],{"trials":1862,"activeCount":95},[],{"trials":1864,"activeCount":95},[],{"trials":1866,"activeCount":95},[1867],{"nctId":1868,"briefTitle":1869,"status":242,"phases":1870,"primaryCompletion":1871,"completion":1871,"start":1872,"enrollment":1873,"conditions":1874,"interventions":1876},"NCT01402869","Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics",[89],"2012-07","2011-08",91,[1875],"Methemoglobinemia",[1853,1877],"2% Lidocaine with 1:100,000 epinephrine",{"intervention":1877,"totalTrials":111,"cells":1879},{"EARLY_PHASE1":1880,"PHASE1":1882,"PHASE2":1884,"PHASE3":1886,"PHASE4":1888,"NA":1890},{"trials":1881,"activeCount":95},[],{"trials":1883,"activeCount":95},[],{"trials":1885,"activeCount":95},[],{"trials":1887,"activeCount":95},[],{"trials":1889,"activeCount":95},[],{"trials":1891,"activeCount":95},[1892],{"nctId":1868,"briefTitle":1869,"status":242,"phases":1893,"primaryCompletion":1871,"completion":1871,"start":1872,"enrollment":1873,"conditions":1894,"interventions":1895},[89],[1875],[1853,1877],{"intervention":1552,"totalTrials":111,"cells":1897},{"EARLY_PHASE1":1898,"PHASE1":1900,"PHASE2":1902,"PHASE3":1904,"PHASE4":1906,"NA":1908},{"trials":1899,"activeCount":95},[],{"trials":1901,"activeCount":95},[],{"trials":1903,"activeCount":95},[],{"trials":1905,"activeCount":95},[],{"trials":1907,"activeCount":95},[],{"trials":1909,"activeCount":95},[1910],{"nctId":1543,"briefTitle":1544,"status":135,"phases":1911,"primaryCompletion":1256,"completion":1546,"start":1547,"enrollment":1548,"conditions":1912,"interventions":1913},[89],[1550,32],[1517,1552,1553,1554,1555],{"intervention":1553,"totalTrials":111,"cells":1915},{"EARLY_PHASE1":1916,"PHASE1":1918,"PHASE2":1920,"PHASE3":1922,"PHASE4":1924,"NA":1926},{"trials":1917,"activeCount":95},[],{"trials":1919,"activeCount":95},[],{"trials":1921,"activeCount":95},[],{"trials":1923,"activeCount":95},[],{"trials":1925,"activeCount":95},[],{"trials":1927,"activeCount":95},[1928],{"nctId":1543,"briefTitle":1544,"status":135,"phases":1929,"primaryCompletion":1256,"completion":1546,"start":1547,"enrollment":1548,"conditions":1930,"interventions":1931},[89],[1550,32],[1517,1552,1553,1554,1555],{"intervention":1554,"totalTrials":111,"cells":1933},{"EARLY_PHASE1":1934,"PHASE1":1936,"PHASE2":1938,"PHASE3":1940,"PHASE4":1942,"NA":1944},{"trials":1935,"activeCount":95},[],{"trials":1937,"activeCount":95},[],{"trials":1939,"activeCount":95},[],{"trials":1941,"activeCount":95},[],{"trials":1943,"activeCount":95},[],{"trials":1945,"activeCount":95},[1946],{"nctId":1543,"briefTitle":1544,"status":135,"phases":1947,"primaryCompletion":1256,"completion":1546,"start":1547,"enrollment":1548,"conditions":1948,"interventions":1949},[89],[1550,32],[1517,1552,1553,1554,1555],{"intervention":1555,"totalTrials":111,"cells":1951},{"EARLY_PHASE1":1952,"PHASE1":1954,"PHASE2":1956,"PHASE3":1958,"PHASE4":1960,"NA":1962},{"trials":1953,"activeCount":95},[],{"trials":1955,"activeCount":95},[],{"trials":1957,"activeCount":95},[],{"trials":1959,"activeCount":95},[],{"trials":1961,"activeCount":95},[],{"trials":1963,"activeCount":95},[1964],{"nctId":1543,"briefTitle":1544,"status":135,"phases":1965,"primaryCompletion":1256,"completion":1546,"start":1547,"enrollment":1548,"conditions":1966,"interventions":1967},[89],[1550,32],[1517,1552,1553,1554,1555],{"intervention":1969,"totalTrials":111,"cells":1970},"Ciprofloxacin",{"EARLY_PHASE1":1971,"PHASE1":1973,"PHASE2":1975,"PHASE3":1977,"PHASE4":1979,"NA":1981},{"trials":1972,"activeCount":95},[],{"trials":1974,"activeCount":95},[],{"trials":1976,"activeCount":95},[],{"trials":1978,"activeCount":95},[],{"trials":1980,"activeCount":95},[],{"trials":1982,"activeCount":95},[1983],{"nctId":1984,"briefTitle":1985,"status":242,"phases":1986,"primaryCompletion":1987,"completion":1987,"start":1988,"enrollment":1989,"conditions":1990,"interventions":1992},"NCT02223338","Bacterial Resistance in Patients Receiving Post-Intravitreal Injection Antibiotics",[89],"2016-05","2014-10",120,[1991],"Bacterial Resistance",[1969,1993],"Standard Aseptic Technique",{"intervention":1993,"totalTrials":111,"cells":1995},{"EARLY_PHASE1":1996,"PHASE1":1998,"PHASE2":2000,"PHASE3":2002,"PHASE4":2004,"NA":2006},{"trials":1997,"activeCount":95},[],{"trials":1999,"activeCount":95},[],{"trials":2001,"activeCount":95},[],{"trials":2003,"activeCount":95},[],{"trials":2005,"activeCount":95},[],{"trials":2007,"activeCount":95},[2008],{"nctId":1984,"briefTitle":1985,"status":242,"phases":2009,"primaryCompletion":1987,"completion":1987,"start":1988,"enrollment":1989,"conditions":2010,"interventions":2011},[89],[1991],[1969,1993],{"intervention":2013,"totalTrials":111,"cells":2014},"Ferric Sulfate",{"EARLY_PHASE1":2015,"PHASE1":2017,"PHASE2":2019,"PHASE3":2021,"PHASE4":2023,"NA":2025},{"trials":2016,"activeCount":95},[],{"trials":2018,"activeCount":95},[],{"trials":2020,"activeCount":95},[],{"trials":2022,"activeCount":95},[],{"trials":2024,"activeCount":95},[],{"trials":2026,"activeCount":95},[2027],{"nctId":2028,"briefTitle":2029,"status":135,"phases":2030,"primaryCompletion":2031,"completion":2031,"start":2032,"enrollment":8,"conditions":2033,"interventions":2036},"NCT02783911","Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies",[89],"2017-03-14","2015-01-29",[2034,2035],"Primary Teeth","Pulpotomy",[2013],{"intervention":2038,"totalTrials":111,"cells":2039},"5% lidocaine patch",{"EARLY_PHASE1":2040,"PHASE1":2042,"PHASE2":2044,"PHASE3":2046,"PHASE4":2048,"NA":2050},{"trials":2041,"activeCount":95},[],{"trials":2043,"activeCount":95},[],{"trials":2045,"activeCount":95},[],{"trials":2047,"activeCount":95},[],{"trials":2049,"activeCount":95},[],{"trials":2051,"activeCount":95},[2052],{"nctId":2053,"briefTitle":2054,"status":395,"phases":2055,"primaryCompletion":2056,"completion":2056,"start":2057,"enrollment":95,"conditions":2058,"interventions":2061},"NCT01307839","Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients",[89],"2012-04","2011-12",[2059,2060],"Pregnant","Labor",[2038],{"intervention":2063,"totalTrials":111,"cells":2064},"Botulinum Toxin, Type A",{"EARLY_PHASE1":2065,"PHASE1":2067,"PHASE2":2069,"PHASE3":2071,"PHASE4":2073,"NA":2075},{"trials":2066,"activeCount":95},[],{"trials":2068,"activeCount":95},[],{"trials":2070,"activeCount":95},[],{"trials":2072,"activeCount":95},[],{"trials":2074,"activeCount":95},[],{"trials":2076,"activeCount":95},[2077],{"nctId":2078,"briefTitle":2079,"status":242,"phases":2080,"primaryCompletion":2081,"completion":1547,"start":1231,"enrollment":2082,"conditions":2083,"interventions":2086},"NCT00822523","Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies",[89],"2009-03",13,[2084,2085],"Muscle Strength","Botulinum Toxins, Type A",[2063,2063,2087],"Saline",{"intervention":2087,"totalTrials":111,"cells":2089},{"EARLY_PHASE1":2090,"PHASE1":2092,"PHASE2":2094,"PHASE3":2096,"PHASE4":2098,"NA":2100},{"trials":2091,"activeCount":95},[],{"trials":2093,"activeCount":95},[],{"trials":2095,"activeCount":95},[],{"trials":2097,"activeCount":95},[],{"trials":2099,"activeCount":95},[],{"trials":2101,"activeCount":95},[2102],{"nctId":2078,"briefTitle":2079,"status":242,"phases":2103,"primaryCompletion":2081,"completion":1547,"start":1231,"enrollment":2082,"conditions":2104,"interventions":2105},[89],[2084,2085],[2063,2063,2087],{"intervention":2107,"totalTrials":111,"cells":2108},"propofol",{"EARLY_PHASE1":2109,"PHASE1":2111,"PHASE2":2113,"PHASE3":2115,"PHASE4":2117,"NA":2119},{"trials":2110,"activeCount":95},[],{"trials":2112,"activeCount":95},[],{"trials":2114,"activeCount":95},[],{"trials":2116,"activeCount":95},[],{"trials":2118,"activeCount":95},[],{"trials":2120,"activeCount":95},[2121],{"nctId":2122,"briefTitle":2123,"status":242,"phases":2124,"primaryCompletion":2125,"completion":2125,"start":2126,"enrollment":2127,"conditions":2128,"interventions":2130},"NCT00616759","The Effect on Cognition of Terminating ECT Induced Seizures With Propofol",[89],"2010-03-24","2006-09",20,[2129],"Major Depression",[2107],{"intervention":2132,"totalTrials":111,"cells":2133},"Zonisamide",{"EARLY_PHASE1":2134,"PHASE1":2136,"PHASE2":2138,"PHASE3":2140,"PHASE4":2142,"NA":2144},{"trials":2135,"activeCount":95},[],{"trials":2137,"activeCount":95},[],{"trials":2139,"activeCount":95},[],{"trials":2141,"activeCount":95},[],{"trials":2143,"activeCount":95},[],{"trials":2145,"activeCount":95},[2146],{"nctId":2147,"briefTitle":2148,"status":135,"phases":2149,"primaryCompletion":634,"completion":2150,"start":2151,"enrollment":16,"conditions":2152,"interventions":2154},"NCT00616343","Zonisamide in the Treatment of Essential Tremor",[89],"2012-12","2003-06",[2153],"Essential Tremor",[2132],{"intervention":2156,"totalTrials":111,"cells":2157},"Immunosuppressive Agents",{"EARLY_PHASE1":2158,"PHASE1":2160,"PHASE2":2162,"PHASE3":2164,"PHASE4":2166,"NA":2168},{"trials":2159,"activeCount":95},[],{"trials":2161,"activeCount":95},[],{"trials":2163,"activeCount":95},[],{"trials":2165,"activeCount":95},[],{"trials":2167,"activeCount":95},[],{"trials":2169,"activeCount":95},[2170],{"nctId":2171,"briefTitle":2172,"status":242,"phases":2173,"primaryCompletion":2174,"completion":2174,"start":2175,"enrollment":2176,"conditions":2177,"interventions":2180},"NCT02294032","The Role of B Cells in Kidney Allograft Dysfunction",[],"2023-04-24","2014-08-28",180,[2178,2179],"Kidney; Complications, Allograft","Transplantation Infection",[2156],{"intervention":2182,"totalTrials":111,"cells":2183},"nitroglycerin",{"EARLY_PHASE1":2184,"PHASE1":2186,"PHASE2":2188,"PHASE3":2190,"PHASE4":2192,"NA":2194},{"trials":2185,"activeCount":95},[],{"trials":2187,"activeCount":95},[],{"trials":2189,"activeCount":95},[],{"trials":2191,"activeCount":95},[],{"trials":2193,"activeCount":95},[],{"trials":2195,"activeCount":95},[2196],{"nctId":2197,"briefTitle":2198,"status":242,"phases":2199,"primaryCompletion":2200,"completion":2200,"start":2201,"enrollment":2202,"conditions":2203,"interventions":2205},"NCT01212874","Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery",[89],"2014-06","2010-12",70,[2204],"Hypertension",[2182,2206],"esmolol",{"intervention":2206,"totalTrials":111,"cells":2208},{"EARLY_PHASE1":2209,"PHASE1":2211,"PHASE2":2213,"PHASE3":2215,"PHASE4":2217,"NA":2219},{"trials":2210,"activeCount":95},[],{"trials":2212,"activeCount":95},[],{"trials":2214,"activeCount":95},[],{"trials":2216,"activeCount":95},[],{"trials":2218,"activeCount":95},[],{"trials":2220,"activeCount":95},[2221],{"nctId":2197,"briefTitle":2198,"status":242,"phases":2222,"primaryCompletion":2200,"completion":2200,"start":2201,"enrollment":2202,"conditions":2223,"interventions":2224},[89],[2204],[2182,2206],{"intervention":2226,"totalTrials":111,"cells":2227},"Sorafenib",{"EARLY_PHASE1":2228,"PHASE1":2230,"PHASE2":2232,"PHASE3":2234,"PHASE4":2236,"NA":2238},{"trials":2229,"activeCount":95},[],{"trials":2231,"activeCount":95},[],{"trials":2233,"activeCount":95},[],{"trials":2235,"activeCount":95},[],{"trials":2237,"activeCount":95},[],{"trials":2239,"activeCount":95},[2240],{"nctId":2241,"briefTitle":2242,"status":135,"phases":2243,"primaryCompletion":2244,"completion":2245,"start":2246,"enrollment":19,"conditions":2247,"interventions":2249},"NCT01141478","Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria",[89],"2014-12-26","2016-06-10","2010-09-08",[2248],"Carcinoma, Hepatocellular",[2226],{"intervention":2251,"totalTrials":111,"cells":2252},"Oral acetaminophen",{"EARLY_PHASE1":2253,"PHASE1":2255,"PHASE2":2257,"PHASE3":2259,"PHASE4":2261,"NA":2263},{"trials":2254,"activeCount":95},[],{"trials":2256,"activeCount":95},[],{"trials":2258,"activeCount":95},[],{"trials":2260,"activeCount":95},[],{"trials":2262,"activeCount":95},[],{"trials":2264,"activeCount":95},[2265],{"nctId":2266,"briefTitle":2267,"status":242,"phases":2268,"primaryCompletion":2269,"completion":2269,"start":2270,"enrollment":2271,"conditions":2272,"interventions":2274},"NCT01500109","Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair",[89],"2014-08","2011-11",45,[2273],"Cleft Palate",[2251,2275,2276],"Ofirmev®","Opioid only",{"intervention":2275,"totalTrials":111,"cells":2278},{"EARLY_PHASE1":2279,"PHASE1":2281,"PHASE2":2283,"PHASE3":2285,"PHASE4":2287,"NA":2289},{"trials":2280,"activeCount":95},[],{"trials":2282,"activeCount":95},[],{"trials":2284,"activeCount":95},[],{"trials":2286,"activeCount":95},[],{"trials":2288,"activeCount":95},[],{"trials":2290,"activeCount":95},[2291],{"nctId":2266,"briefTitle":2267,"status":242,"phases":2292,"primaryCompletion":2269,"completion":2269,"start":2270,"enrollment":2271,"conditions":2293,"interventions":2294},[89],[2273],[2251,2275,2276],{"intervention":2276,"totalTrials":111,"cells":2296},{"EARLY_PHASE1":2297,"PHASE1":2299,"PHASE2":2301,"PHASE3":2303,"PHASE4":2305,"NA":2307},{"trials":2298,"activeCount":95},[],{"trials":2300,"activeCount":95},[],{"trials":2302,"activeCount":95},[],{"trials":2304,"activeCount":95},[],{"trials":2306,"activeCount":95},[],{"trials":2308,"activeCount":95},[2309],{"nctId":2266,"briefTitle":2267,"status":242,"phases":2310,"primaryCompletion":2269,"completion":2269,"start":2270,"enrollment":2271,"conditions":2311,"interventions":2312},[89],[2273],[2251,2275,2276],{"intervention":2314,"totalTrials":111,"cells":2315},"Piperacillin\u002FTazobactam Standard Dose to High Dose",{"EARLY_PHASE1":2316,"PHASE1":2318,"PHASE2":2320,"PHASE3":2322,"PHASE4":2324,"NA":2326},{"trials":2317,"activeCount":95},[],{"trials":2319,"activeCount":95},[],{"trials":2321,"activeCount":95},[],{"trials":2323,"activeCount":95},[],{"trials":2325,"activeCount":95},[],{"trials":2327,"activeCount":95},[2328],{"nctId":2329,"briefTitle":2330,"status":242,"phases":2331,"primaryCompletion":2332,"completion":2332,"start":2333,"enrollment":2334,"conditions":2335,"interventions":2336},"NCT01923363","PK\u002FPD of High Dose Pip\u002FTazo in Obese Patients",[89],"2016-01-23","2014-02-25",29,[15],[2314],{"intervention":2338,"totalTrials":111,"cells":2339},"Equimatrix",{"EARLY_PHASE1":2340,"PHASE1":2342,"PHASE2":2344,"PHASE3":2346,"PHASE4":2348,"NA":2350},{"trials":2341,"activeCount":95},[],{"trials":2343,"activeCount":95},[],{"trials":2345,"activeCount":95},[],{"trials":2347,"activeCount":95},[],{"trials":2349,"activeCount":95},[],{"trials":2351,"activeCount":95},[2352],{"nctId":2353,"briefTitle":2354,"status":242,"phases":2355,"primaryCompletion":2356,"completion":2356,"start":2357,"enrollment":2358,"conditions":2359,"interventions":2361},"NCT01911819","A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft",[89],"2016-06","2013-12",22,[2360],"Inadequate Bone Height in Maxillary Posterior Area",[2338,2362,2363],"OSSIF-i sem","Bio-oss",{"intervention":2362,"totalTrials":111,"cells":2365},{"EARLY_PHASE1":2366,"PHASE1":2368,"PHASE2":2370,"PHASE3":2372,"PHASE4":2374,"NA":2376},{"trials":2367,"activeCount":95},[],{"trials":2369,"activeCount":95},[],{"trials":2371,"activeCount":95},[],{"trials":2373,"activeCount":95},[],{"trials":2375,"activeCount":95},[],{"trials":2377,"activeCount":95},[2378],{"nctId":2353,"briefTitle":2354,"status":242,"phases":2379,"primaryCompletion":2356,"completion":2356,"start":2357,"enrollment":2358,"conditions":2380,"interventions":2381},[89],[2360],[2338,2362,2363],{"intervention":2363,"totalTrials":111,"cells":2383},{"EARLY_PHASE1":2384,"PHASE1":2386,"PHASE2":2388,"PHASE3":2390,"PHASE4":2392,"NA":2394},{"trials":2385,"activeCount":95},[],{"trials":2387,"activeCount":95},[],{"trials":2389,"activeCount":95},[],{"trials":2391,"activeCount":95},[],{"trials":2393,"activeCount":95},[],{"trials":2395,"activeCount":95},[2396],{"nctId":2353,"briefTitle":2354,"status":242,"phases":2397,"primaryCompletion":2356,"completion":2356,"start":2357,"enrollment":2358,"conditions":2398,"interventions":2399},[89],[2360],[2338,2362,2363],{"intervention":2401,"totalTrials":111,"cells":2402},"intravenous immune globulin",{"EARLY_PHASE1":2403,"PHASE1":2405,"PHASE2":2407,"PHASE3":2409,"PHASE4":2411,"NA":2413},{"trials":2404,"activeCount":95},[],{"trials":2406,"activeCount":95},[],{"trials":2408,"activeCount":95},[],{"trials":2410,"activeCount":95},[],{"trials":2412,"activeCount":95},[],{"trials":2414,"activeCount":95},[2415],{"nctId":2416,"briefTitle":2417,"status":135,"phases":2418,"primaryCompletion":2419,"completion":2420,"start":2421,"enrollment":2358,"conditions":2422,"interventions":2424},"NCT00586716","Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients",[89],"2009-09","2009-10","2004-11",[2423],"End Stage Renal Disease",[2401],{"intervention":2426,"totalTrials":111,"cells":2427},"Ketamine",{"EARLY_PHASE1":2428,"PHASE1":2430,"PHASE2":2432,"PHASE3":2434,"PHASE4":2436,"NA":2438},{"trials":2429,"activeCount":95},[],{"trials":2431,"activeCount":95},[],{"trials":2433,"activeCount":95},[],{"trials":2435,"activeCount":95},[],{"trials":2437,"activeCount":95},[],{"trials":2439,"activeCount":95},[2440],{"nctId":2441,"briefTitle":2442,"status":395,"phases":2443,"primaryCompletion":2444,"completion":2444,"start":2445,"enrollment":95,"conditions":2446,"interventions":2448},"NCT04283058","Low Dose Ketamine Infusion for the Treatment of Resistant Depression",[],"2020-12-29","2020-06-29",[2447],"Depression",[2426]]